Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study.

Rheumatol Ther · 2021 · PMC8572263 · PMID 34448173

Europe PMC DOI

hedged sentence

0.0884

closest p · 1.8× alpha

0.0884

boldest claim

The sentences

did not reach statistical significancep = 0.0884so close (0.05 < p ≤ 0.1)

Comparison of Abatacept Efficacy by Age Group Assessment of abatacept efficacy in younger and older patients showed that a numerically smaller proportion of patients in the AO group had a EULAR good response at week 24 compared with the AY group, although this difference did not reach statistical significance (31.3 vs. 48.9%, OR: 0.476, 95% CI 0.220–1.029, p = 0.0884) (Fig. 4 a).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.